Literature DB >> 20042983

Predictors of psychiatric disorders following traumatic brain injury.

Rochelle Whelan-Goodinson1, Jennie Louise Ponsford, Michael Schönberger, Lisa Johnston.   

Abstract

OBJECTIVE: To investigate predictors of posttraumatic brain injury psychiatric disorders.
DESIGN: Retrospective, cross-sectional design with stratified random sampling of groups of patients on average 1 to 5 years postinjury. DSM-based diagnostic interviews of both traumatic brain injury (TBI) participant and informant. PARTICIPANTS: One hundred community-based participants, aged 19-74 years, with traumatic brain injury sustained 0.05-5.5 years previously.
SETTING: Community-based patients previously treated at a rehabilitation hospital. MAIN MEASURE: The Structured Clinical Interview for DSM-IV diagnosis.
RESULTS: A psychiatric history was a high-risk factor for having the same disorder postinjury. However, the majority of cases of depression and anxiety were novel, suggesting that significant factors other than pre-TBI psychiatric status contribute to post-TBI psychiatric outcome. Female gender, lower education, and pain were also associated with postinjury depression and unemployment and older age with anxiety.
CONCLUSION: Findings suggest that long-term screening and support are important for individuals with TBI, regardless of preinjury psychiatric status.

Entities:  

Mesh:

Year:  2010        PMID: 20042983     DOI: 10.1097/HTR.0b013e3181c8f8e7

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  14 in total

1.  [Medicolegal evaluation of traumatic brain injury].

Authors:  C-W Wallesch; R Schmidt
Journal:  Nervenarzt       Date:  2011-12       Impact factor: 1.214

Review 2.  Mental Health in Women With Traumatic Brain Injury: A Systematic Review on Depression and Hope.

Authors:  Tolu O Oyesanya; Earlise C Ward
Journal:  Health Care Women Int       Date:  2015-01-30

Review 3.  Depression following traumatic brain injury: epidemiology, risk factors and management.

Authors:  Mark J Rapoport
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

4.  Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know.

Authors:  Raeesa Gupte; William Brooks; Rachel Vukas; Janet Pierce; Janna Harris
Journal:  J Neurotrauma       Date:  2019-07-19       Impact factor: 5.269

5.  Neurological Symptoms and Their Associations With Inflammatory Biomarkers in the Chronic Phase Following Traumatic Brain Injuries.

Authors:  Gangqin Li; Hao Liu; Yong He; Zeqing Hu; Yan Gu; Yan Li; Yi Ye; Junmei Hu
Journal:  Front Psychiatry       Date:  2022-06-24       Impact factor: 5.435

Review 6.  Mood disorders after TBI.

Authors:  Ricardo E Jorge; David B Arciniegas
Journal:  Psychiatr Clin North Am       Date:  2014-01-14

7.  Depression Trajectories during the First Year after Traumatic Brain Injury.

Authors:  Charles H Bombardier; Trynke Hoekstra; Sureyya Dikmen; Jesse R Fann
Journal:  J Neurotrauma       Date:  2016-05-06       Impact factor: 5.269

8.  Early trajectory of psychiatric symptoms after traumatic brain injury: relationship to patient and injury characteristics.

Authors:  Tessa Hart; Emma K T Benn; Emilia Bagiella; Patricia Arenth; Sureyya Dikmen; Dale C Hesdorffer; Thomas A Novack; Joseph H Ricker; Ross Zafonte
Journal:  J Neurotrauma       Date:  2014-01-10       Impact factor: 5.269

9.  Endogenous Sex Steroids Dampen Neuroinflammation and Improve Outcome of Traumatic Brain Injury in Mice.

Authors:  Amy C Clevenger; Hoon Kim; Ernesto Salcedo; Joan C Yonchek; Krista M Rodgers; James E Orfila; Robert M Dietz; Nidia Quillinan; Richard J Traystman; Paco S Herson
Journal:  J Mol Neurosci       Date:  2018-02-15       Impact factor: 3.444

10.  Sex Differences in Acute Neuroinflammation after Experimental Traumatic Brain Injury Are Mediated by Infiltrating Myeloid Cells.

Authors:  Sarah J Doran; Rodney M Ritzel; Ethan P Glaser; Rebecca J Henry; Alan I Faden; David J Loane
Journal:  J Neurotrauma       Date:  2018-11-16       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.